CYN.NASDAQCyngn INC

8-K: Cyngn to Restate Financials Due to Warrant Accounting Error

Sentiment:

Financial Restatement Announcement


Cyngn Inc. announced it will restate previously issued financial statements from 2024 and 2025 due to an error in accounting for Series A and Series B Warrants, leading to a material weakness in internal controls.

Delay expectedThe company will need to file an amended Annual Report on Form 10-K for the fiscal year ended December 31, 2024.The restated March 31, 2025, and June 30, 2025, financial statements will be included in the Quarterly Report on Form 10-Q for the period ended September 30, 2025, indicating a delay in the standalone Q1 and Q2 filings or their accuracy.
Worse than expectedPreviously issued financial statements for fiscal year 2024 and Q1/Q2 2025 can no longer be relied upon.The company identified an additional material weakness in its internal control over financial reporting and disclosure controls and procedures.The error resulted in a significant estimated increase to warrant liability by $12.7 million and a decrease in equity balance by $12.7 million.The company will recognize an estimated loss on the issuance of warrants of $2.3 million and offering-related issuance costs of $1.7 million.

Summary

  • Cyngn Inc. will restate its audited financial statements for the fiscal year ended December 31, 2024, and unaudited condensed consolidated financial statements for the periods ended March 31, 2025, and June 30, 2025.
  • The restatement is due to an error in accounting for Series A and Series B Warrants issued under a Securities Purchaser Agreement dated December 20, 2024.
  • The error resulted in an estimated increase to warrant liability by $12.7 million and a decrease in equity balance by $12.7 million as of December 31, 2024.
  • A reclassification from operating activities to financing activities on the statement of cash flow as of December 31, 2024, is also required.
  • The company estimates a loss on warrant issuance of approximately $2.3 million and offering-related issuance costs of approximately $1.7 million as of December 31, 2024.
  • The error also materially changed quarterly financial statements, with an estimated increase of $402 thousand to additional paid-in-capital and a decrease of $3.7 million in net loss.
  • The error has no impact on total cash, revenue, or operating performance.
  • Management identified an additional material weakness in internal control over financial reporting and disclosure controls and procedures as of December 31, 2024.
  • The company plans to hire a third-party expert to remediate the material weakness, expecting full remediation by Q1 2026.
  • The Audit Committee discussed these matters with CBIZ CPAs P.C., the independent registered accounting firm.
  • The Clawback Policy will not require recovery of awarded compensation.

Sentiment

Score: 3

Explanation: The restatement of financial statements, significant adjustments to warrant liability and equity, and the identification of a material weakness in internal controls are all negative indicators. While the error has no impact on cash or revenue, the control weakness and need for restatement signal operational and financial reporting issues that could erode investor confidence and potentially lead to further scrutiny or delays.

Positives

  • The accounting error has no impact on total cash, revenue, or operating performance.
  • The company is actively working to remediate the identified material weakness by hiring a third-party expert.
  • The Clawback Policy will not require recovery of awarded compensation, indicating no executive misconduct related to the error.

Negatives

  • Previously issued audited financial statements for fiscal year 2024 and unaudited condensed consolidated financial statements for Q1 and Q2 2025 can no longer be relied upon and require restatement.
  • Estimated increase to warrant liability by $12.7 million and decrease in equity balance by $12.7 million as of December 31, 2024.
  • Estimated loss on warrant issuance of approximately $2.3 million and offering-related issuance costs of approximately $1.7 million as of December 31, 2024.
  • Identification of an additional material weakness in internal control over financial reporting and disclosure controls and procedures as of December 31, 2024.
  • Investors should no longer rely on prior earnings releases and other communications relating to the Prior Financial Statements.

Risks

  • The timing and nature of the resolution of the accounting issues discussed in this report.
  • Any potential delay in the filing of required periodic reports.
  • The possibility that a restatement of financial results will be required for other accounting issues not yet identified.
  • Adverse effects on the company's business related to the disclosures made in this Current Report on Form 8-K.
  • Volatility of the company's stock price due to investor uncertainty or negative market reaction.

Future Outlook

The company expects to complete the filing of its amended Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and will include the restated Q1 and Q2 2025 financial statements within the Quarterly Report on Form 10-Q for the period ended September 30, 2025. Management anticipates the identified material weakness in internal controls to be fully remediated and tested by the first quarter of 2026.

Management Comments

  • "The Company intends to hire a third-party expert to evaluate any complex accounting transaction."
  • "The Company expects the material weakness to be fully remediated and tested by the first quarter of 2026."

Industry Context

This announcement is specific to Cyngn's internal accounting practices and does not directly reflect broader industry trends. However, accounting errors and restatements, particularly related to complex financial instruments like warrants, are not uncommon across industries, highlighting the ongoing challenges companies face in maintaining robust internal controls and complying with evolving accounting standards.

Comparison to Industry Standards

  • NA. This filing concerns an internal accounting error and restatement, not operational or financial performance that can be directly compared to industry benchmarks or competitors' results.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control WeaknessManagement identified an additional material weakness in the company's internal control over financial reporting and disclosure controls and procedures as of December 31, 2024, related to the accounting error.2024-12-31This weakness indicates a deficiency in the company's ability to prevent or detect material misstatements in its financial statements, requiring significant remediation efforts and potentially impacting investor confidence.
Remediation PlanThe company intends to hire a third-party expert to evaluate complex accounting transactions to remediate the material weakness.NAThis is a proactive step to address the identified control deficiency, aiming to strengthen financial reporting processes and restore confidence, with expected full remediation by Q1 2026.

Stakeholder Impact

  • Shareholders will experience uncertainty due to unreliable past financial statements, potential stock price volatility, and concerns about internal controls. The decrease in equity balance by $12.7 million directly impacts shareholder equity.
  • Investors should no longer rely on previously issued financial statements, earnings releases, and related communications, requiring them to await restated reports for accurate financial data.
  • Management faces increased scrutiny and workload to correct the errors, remediate internal control weaknesses, and restore investor confidence.
  • Auditors (CBIZ CPAs P.C.) will be involved in reviewing the restated financials and the remediation efforts, potentially incurring additional costs for the company.

Next Steps

  • Complete the filing of the amended Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
  • Include the restated March 31, 2025, and June 30, 2025, financial statements within the Quarterly Report on Form 10-Q for the period ended September 30, 2025.
  • Hire a third-party expert to evaluate complex accounting transactions to remediate the material weakness.
  • Remediate and test the material weakness in internal control over financial reporting by Q1 2026.

Key Dates

DateDescription
2024-12-20Date of Securities Purchaser Agreement for Series A and Series B Warrants.
2024-12-31Fiscal year end for which audited financial statements require restatement; date as of which warrant liability increased by $12.7 million and equity decreased by $12.7 million; date as of which material weakness in internal control was identified.
2025-03-06Original filing date of Annual Report on Form 10-K for fiscal year ended December 31, 2024.
2025-03-31Period end for unaudited condensed consolidated financial statements requiring restatement.
2025-05-08Original filing date of Quarterly Report on Form 10-Q for period ended March 31, 2025.
2025-06-30Period end for unaudited condensed consolidated financial statements requiring restatement.
2025-08-06Original filing date of Quarterly Report on Form 10-Q for period ended June 30, 2025.
2025-09-30Period end for which restated March 31, 2025 and June 30, 2025 financial statements will be included in the Quarterly Report on Form 10-Q.
2025-11-04Date the Audit Committee and Board concluded previously issued financial statements should no longer be relied upon.
2025-11-07Date the 8-K report was signed.
2026-03-31Expected quarter for full remediation and testing of the material weakness.

Recommendation

sell

The restatement of multiple financial periods due to a significant accounting error, coupled with the identification of a material weakness in internal controls, signals serious deficiencies in financial reporting and oversight. While the error reportedly doesn't impact cash or revenue, the erosion of trust in reported financials and the need for extensive remediation create substantial uncertainty and risk. This situation often leads to negative market reaction and increased scrutiny, making it prudent for investors to consider selling or avoiding the stock until these issues are fully resolved and confidence in the company's financial integrity is restored.

Keywords

Cyngn, CYN, SEC filing, 8-K, financial restatement, warrant accounting, material weakness, internal controls, financial reporting error, equity decrease, warrant liability, Nasdaq

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.